Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07830576 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to construct and validate a multimodal survival prediction model by integrating 3D radiomics features derived from preoperative magnetic resonance imaging (MRI) with systemic clinical baseline indicators for patients with colorectal liver metastases (CRLM) after surgery. By combining micro-level radiomics signatures reflecting tumor micro-heterogeneity with macro-level clinical parameters (such as liver function and tumor biomarkers), the study aims to accurately evaluate individual post-operative prognostic risks. This quantitative tool will provide reliable decision support for clinicians to customize post-operative follow-up and personalized adjuvant treatment strategies.
Trial Details
NCT Number NCT07830576
Lead Sponsor Anhui Provincial Hospital
Collaborators: Anhui Provincial Cancer Hospital
Conditions
(from sponsor)		 Colorectal Liver Metastases, Colorectal Neoplasms, Liver Neoplasms
Related terms Colorectal Neoplasms, Liver Neoplasms
Enrollment 205 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov